Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
False
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
By Yiting Lim
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
By Dara McCreary
February 19, 2026
Scaling genomics with AI and automation is one thing, but building the infrastructure to support it is what will really drive innovation in the space
3 min read
February 19, 2026
New board will identify opportunities for the advanced therapies sector to deploy and benefit from innovations
2 min read
February 13, 2026
Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing
2 min read
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
January 27, 2026
Collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials
2 min read
January 26, 2026
Number of early-stage trials remains high, according to CGT Catapult data
1 min read
False
False
False